Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant electrochemotherapy for colorectal cancer
2025-520755-91-00Phase 2Suspended
- Sponsor
- Region Zealand
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of bleomycin in colorectal cancer (CRC), rectal cancer and sigmoid colon cancer (2 arms), sponsored by Region Zealand. Primary endpoints: Serious adverse events between study treatment and surgery and Any adverse events within 30 days after study treatment. Started Jan 2025; status: suspended.
02
Drugs
bleomycin
03
Conditions
colorectal cancer (CRC)rectal cancersigmoid colon cancer
Beyond the preview
Go deeper on 2025-520755-91-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520755-91-00.